Abstract
The aim of this study is to synthesize 125I-labeled 2-(4-iodophenethyl)-2-methylmalonic acid ([125I]IMA) for the development of new apoptosis imaging tracer. The optimized radiolabeling procedure provided [125I]IMA with high radiochemical yield (75.5 ± 5.2 %) and radiochemical purity (>99 %) within 100 min. Specific radioactivity of [125I]IMA was 31.0 MBq/μmol. Biodistribution study of [125I]IMA was carried out using ICR mouse and the result showed the uptake values in apoptotic cells of the testes of the male mice were 1.7–3.2 fold higher than those of leg muscle. Therefore, [125I]IMA will be a promising radiotracer for in vivo SPECT imaging of apoptotic cells.
Original language | English |
---|---|
Pages (from-to) | 23-29 |
Number of pages | 7 |
Journal | Journal of Radioanalytical and Nuclear Chemistry |
Volume | 308 |
Issue number | 1 |
DOIs | |
State | Published - 1 Apr 2016 |
Keywords
- I
- Apoptosis
- Biodistribution
- Radiotracer
- SPECT/CT